Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactions.
暂无分享,去创建一个
L. Zhong | H. Derendorf | S. Schmidt | C. Clancy | M. Nguyen | Yanjun Li
[1] L. Zhong,et al. A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro. , 2008, International journal of antimicrobial agents.
[2] H. Derendorf,et al. Measurement of Voriconazole Activity against Candida albicans, C. glabrata, and C. parapsilosis Isolates Using Time-Kill Methods Validated by High-Performance Liquid Chromatography , 2007, Antimicrobial Agents and Chemotherapy.
[3] H. Derendorf,et al. Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains. , 2007, International journal of antimicrobial agents.
[4] D. Andes,et al. Voriconazole Therapeutic Drug Monitoring , 2006, Antimicrobial Agents and Chemotherapy.
[5] M. Ghannoum,et al. Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints , 2006, Journal of Clinical Microbiology.
[6] E. Schuck,et al. Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of a Once-Daily Treatment Using Ciprofloxacin in an Extended-Release Dosage Form* , 2005, Infection.
[7] D. Andes,et al. In Vivo Pharmacokinetics and Pharmacodynamics of a New Triazole, Voriconazole, in a Murine Candidiasis Model , 2003, Antimicrobial Agents and Chemotherapy.
[8] N. Wood,et al. Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation Regimens , 2002, Antimicrobial Agents and Chemotherapy.
[9] Russell E. Lewis,et al. Evaluation of Voriconazole Pharmacodynamics Using Time-Kill Methodology , 2000, Antimicrobial Agents and Chemotherapy.
[10] J. Rex,et al. Microdilution Susceptibility Testing of Amphotericin B, Itraconazole, and Voriconazole against Clinical Isolates of Aspergillus and FusariumSpecies , 1999, Journal of Clinical Microbiology.
[11] M. Rinaldi,et al. In vitro activity of voriconazole against selected fungi. , 1998, Medical mycology.
[12] A. Espinel-Ingroff. In Vitro Activity of the New Triazole Voriconazole (UK-109,496) against Opportunistic Filamentous and Dimorphic Fungi and Common and Emerging Yeast Pathogens , 1998, Journal of Clinical Microbiology.
[13] Clinical,et al. Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .
[14] H. Derendorf,et al. Pharmacokinetic/Pharmacodynamic Profile of Voriconazole , 2006, Clinical pharmacokinetics.